Concepedia
Statistics
Publications
5
Citations
197
H-Index
Active since
2005
Affiliations
Pfizer (United States)(Current)
Pfizer (United Kingdom)
University of Milano-Bicocca
Princess Margaret Cancer Centre
Universität Hamburg
Roxanne Ferdinand is an author at Pfizer (United States) specializing in cancer research, medicine, and oncology.
Top concepts
MedicineOncologyCancer ResearchRaceRacismEthnicityHematologyPharmacologyBlack StudiesHealth Equity
Publications per year
2005–2021
Metabolic Assessment of Human Liver Transplants from Biopsy Samples at the Donor and Recipient Stages Using High-Resolution Magic Angle Spinning <sup>1</sup>H NMR Spectroscopy
Iola F. Duarte, Elizabeth Stanley, Elaine Holmes et al. · Analytical Chemistry · 2005 · 104 citations
Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy
Jörge E. Cortes, Florian H. Heidel, Walter Fiedler et al. · Journal of Hematology & Oncology · 2020 · 36 citations · Full text
Efficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosome‒positive leukemias
Vamsi Kota, Tim H. Brümmendorf, Carlo Gambacorti‐Passerini et al. · Leukemia Research · 2021 · 25 citations
Hematological Malignancy, Oncology, Hematology +7
Addressing racial/ethnic disparities in cancer clinical trials: Everyone has a role to play
Dany Habr, Roxanne Ferdinand · Cancer · 2021 · 19 citations · Full text
Ethnicity, Health Care Disparity, Therapeutic Clinical Trials +24
Efficacy and Safety Following Dose Reduction of Bosutinib or Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia: Analysis of the Phase 3 BFORE Trial
Tim H. Brümmendorf, Carlo Gambacorti‐Passerini, Andreas Hochhaus et al. · Blood · 2018 · 13 citations
1–5 of 5